ERBB2 and breast carcinoma: HER3 expression was highest in HER2+ breast cancer, with a mean of 4.2 ± 4.97 (AU), followed by the HR+ at 3.06 ± 3.02 (AU), and TNBC 1.14 ± 0.82 (AU).